Injective could dip further as futures Open Interest drops

Injective (INJ) trades around $7.42, extending losses after a 5.7% decline. Futures taker buy-to-sell ratio stands at 0.96, with sell orders at 51.1%, indicating sellers retain an edge. A breakdown below the $7.19 trendline support could expose INJ to further downside.